As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bristol-Myers Squibb: Total Wealth Planning & Management Inc., Wolverine Trading LLC, Squarepoint Ops LLC, Nomura Holdings Inc., Maven Securities LTD, Millennium Management LLC, Moore Capital Management LP, Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Cetera Investment Advisers, Cantor Fitzgerald L. P., Citadel Advisors LLC, Capstone Investment Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Lido Advisors LLC, Tudor Investment Corp ET AL, CMT Capital Markets Trading GmbH, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Susquehanna International Group LLP, HAP Trading LLC, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Wells Fargo & Company MN, JPMorgan Chase & Co., LPL Financial LLC, Simplex Trading LLC, Delta Accumulation LLC, Fulcrum Asset Management LLP, Allianz Asset Management GmbH, Wolverine Asset Management LLC, Genus Capital Management Inc., IMC Chicago LLC, CenterStar Asset Management LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.